| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |